Nonspecific inhibitors of rubella hemagglutination can be removed by treatment of sera with heparin-manganous chloride for use in the hemagglutinationinhibition test. After removal of nonspecific inhibitors by this procedure, an excess of manganous chloride may remain. This may cause the cells to agglutinate, thus obscuring the reading at low serum dilutions. This disadvantage can be overcome by the addition of sodium carbonate, which forms an insoluble compound with manganous chloride and does not interfere with antibody determination. The procedure presents a further refinement of the hemagglutination inhibition test for rubella by increasing specificity and sensitivity; it permits detection of antibody levels as low as 1:4 in sera.
The most significant sources of error associated with the hemagglutination inhibition (HI) test for antibody to rubella virus arise from the presence of non-immunoglobulin inhibitors of rubella hemagglutinin (they are present in almost all sera at titers that range from 1:4 to 1:200) and from the procedures used to remove them (4) . Inhibitors have been removed by a number of methods. One of these involves the use of heparin-manganous chloride (H-MnCl2; [5] ). Although precipitation of inhibitors with H-MnCl2 is specific in its action and generally reliable when carried out by skilled personnel, it is often complicated by the occurrence of nonspecific hemagglutination, which obscures the reading of the test at low serum dilutions despite repeated absorption of the serum with 50% chick erythrocytes. This disadvantage may lead to serious error when the immunity status of pregnant women is considered, by preventing detection of antibody at low serum dilutions.
Attempts have been made to correct this drawback (3) . By reducing the concentration of MnCl2, nonspecific agglutination was minimized, but the nonspecific inhibitors were not always completely removed. The heating of the serum at 56 C for 15 min prior to absorption with chick erythrocytes also reduced the appearance of nonspecific agglutination but did not eliminate it.
This study is concerned with determining the cause of nonspecific agglutination in the HMnCl2 procedure and with attempting to correct it without interfering with antibody deter- Of 2,000 sera tested by the standard procedure, 573 showed a titer of less than 1:16, which means that 28.6% had no demonstrable antibody. The 573 women were followed, and a second specimen was drawn at delivery time, as well as cord blood from the infant. Paired maternal sera and cord were run in the same VOL. 28, 1974 BIANO, CHANG, AND DANIELS test by the procedure described above. Of the 28.6% of the women initially showing an HI titer of less than 1:16, more than half had a titer of 1:8 or 1:4, and less than half showed a titer of less than 1:4 ( Table 2 ). This means that more than half of the women originally considered "nonimmune" proved to have low titers of antibody, and the group of women susceptible to rubella was smaller. The results on 300 cord sera corresponded with maternal sera. Despite the use of the H-MnCl2-Na2CO3 procedure and repeated absorption with chick erythrocytes, for some unknown reason we failed to eliminate nonspecific agglutination in the 1:4 dilution of 2 to 4% of the sera and cord bloods, and therefore we were not able to read the 1:4 dilution.
To investigate the reliability of the test and to answer the question of whether low HI titers were truly antibody, a comparison was made with immunofluorescent antibody determination. Sixteen sera collected from women at delivery and 16 cord sera from their infants were coded and tested by immunofluorescence. There was agreement in titers of antibody (Table 3 ). In only one set out of 16 (specimen 409) the results were different; they were positive on fluorescent antibody and negative on HI in repeated tests, but the sera were found to have bacterial contamination. Thus, specificity of low levels of HI antibody was confirmed by indirect fluorescence, and these data suggested a high correlation between the two tests.
With a more sensitive HI test, we may be able to better document reinfection in individuals with low antibody levels, and also perhaps to determine that antibody level which protects the fetus. determined.
±, equivocal; +, positive; ND, not
The modified H-MnCl2-NaC0, procedure for removing nonspecific inhibitors was easy to perform and effective. It combined sensitivity with specificity in HI antibody determination.
